FibroGen   Report issue

Founded: San Francisco CA United States (1993)

Organization Overview

First Clinical Trial
2003
NCT00074698
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

FibroGen